SentiAR, a ST. Louis, MO-based visualization technology platform for interventional procedures, closed a $5.1m Series A financing.
Backers included TechWald Holding, BioGenerator (the investment arm of BioSTL), Cultivation Capital, VCapital, Neue Fund, QRM Capital, and Keiretsu Forum.
The company intends to use the funds to accelerate innovation on its mixed reality The FDA 510(k) cleared CommandEP™ system.
Led by Berk Tas, CEO, SentiAR is developing an application of Mixed Reality technology for use during interventional procedures, starting with cardiac ablation procedures, including the treatment of atrial fibrillation.
Based on research spun out from Washington University in St. Louis by Dr. Jennifer Silva MD, Associate Professor of Pediatric Cardiology, and Dr. Jonathan Silva Ph.D., Associate Professor of Biomedical Engineering, CommandEP system receives imaging data from electroanatomic mapping systems and creates a 3D holographic image via proprietary data flow and visualization algorithms. This patented system presents a 3D image of the patient’s heart showing the real-time positions of catheters used for the procedure via a wearable headset. In addition to their proprietary algorithms, SentiAR deploys a custom AR engine to deliver uncompromising performance.